Aligos Therapeutics, Inc 10-Q for FY2025 Q2
Aligos Therapeutics, Inc. (ALGS)
10-Q
2025-08-06
For: 2025-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Aligos Therapeutics, Inc filed this 10-Q on August 6, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $965K
- down 9.0% from $1.06M a year earlier
- Net loss
- $15.86M
- compared with net income of $5.06M a year earlier
- Diluted EPS
- -$1.53
- compared with $0.81 a year earlier